Eczema Vaccine Response Trial (36 Weeks)

Men and women aged 18 to 54 with a history of eczema (atopic dermatitis) for at least one year,may qualify to participate in this study. Individuals must have moderate to severe disease, involving 10% or more of their body. To be eligible, participants must also have a recent history of inadequate response to treatment with topical medications.

Participants will receive investigational medication via injection (either active study drug or placebo). One dose each of two vaccines will be administered at one visit during the study. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 36 weeks and involve about 12 visits to the study clinic. In addition, 2 visits will occur by telephone.

Call the study centre near you or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more